GeNeuro

GeNeuro is a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases. The company primarily focuses on neurological disorders such as multiple sclerosis and schizophrenia. Its products include GNbAC1, a therapeutic monoclonal antibody used in the treatment of multiple sclerosis. It also develops diagnostic tests to detect multiple sclerosis-associated retroviral ENV proteins in patients.